A novel aryl hydrocarbon receptor antagonist hbu651 ameliorates peripheral and hypothalamic inflammation in high-fat diet-induced obese mice

HIGHLIGHTS

• who: Sora Kang and colleagues from the Department of Neuroscience, Graduate School, Kyung Hee University, Seoul, Republic of Korea have published the research work: A Novel Aryl Hydrocarbon Receptor Antagonist HBU651 Ameliorates Peripheral and Hypothalamic Inflammation in High-Fat Diet-Induced Obese Mice, in the Journal: (JOURNAL) of 10/Nov/2022
• what: The authors evaluated the anti-obesity and anti-inflammatory activity of a novel AhR
• how: To evaluate therapeutic efficacy on insulin resistance the authors investigated the effect of HBU651 on inflammation using LPS-stimulated BV2 cells and an HFD-induced obese . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.